Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to develop and test a multicomponent hearing care intervention for the PACE staff members in order to learn more about communication and engagement.


Clinical Trial Description

The long-term objective of this proposal is to increase the accessibility and affordability of hearing loss treatment for older adults with hearing loss, with a particular interest in adults that have mild cognitive impairment (MCI) or dementia. Age-related hearing loss (ARHL) in persons with MCI or dementia may exacerbate dementia-related symptoms such as depression, apathy, agitation/aggression. Moreover, engagement and activity participation are recognized as critical aspects of dementia care management, but those individuals who also experience ARHL are at a disadvantage. A pilot testing of behavioral communication intervention will be completed at multiple Program for All-inclusive Care for the Elderly (PACE) sites in New England. A multicomponent hearing care intervention will be tested that includes staff training and non-custom personal amplification use with older adults in a group care setting. This feasibility study will lead to the refinement of the intervention protocols to be used in a future grant application that will test the real-world efficacy of the intervention. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04659967
Study type Interventional
Source University of Massachusetts, Amherst
Contact
Status Active, not recruiting
Phase N/A
Start date December 2, 2020
Completion date June 30, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05694039 - A Prospective Cohort Study On Change of Cognitive Function In Aged-related Hearing Loss With Hearing Aids N/A
Withdrawn NCT04431622 - Objective Measurement of Hearing Aid Benefit N/A
Recruiting NCT05796011 - PET-CT-based Study of Central Mechanisms of Cortical Metabolism in 18F-FDG and 18F-AV1451 Age-related Deafness
Recruiting NCT05125081 - Efficacy and Safety of Liuwei Dihuang Pill Versus Placebo in Presbycusis With Shen (Kidney)-Yin Deficiency Phase 2
Completed NCT02345031 - Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss Phase 2
Active, not recruiting NCT05892731 - Study of Cognitive Reserve Disorder Affecting Depression in Aged Related Hearing Loss Via Rest State EEG
Not yet recruiting NCT05706051 - Postural Modification and Hearing Aids in Presbycusis N/A
Completed NCT01732289 - Genetic Study of Age Related Hearing Loss Phase 0